New Lassa Vaccine Trial in Nigeria

The International AIDS Vaccine Initiative (IAVI) was awarded €22.8 million by the European & Developing Countries Clinical Trials Partnership and the Coalition for Epidemic Preparedness Innovations (CEPI) to conduct a Phase IIb clinical trial of IAVI’s Lassa fever vaccine candidate among adults and children in Liberia, Nigeria, and Sierra Leone.  The vaccine candidate uses a ...
Read More»

U.S. Government Supports Additional 45,000 People Living with HIV in Oyo, Ondo States

Ibadan and Akure––The U.S. government will identify and place an additional 45,000 People Living with HIV (PLHIV) in Oyo and Ondo states on life-saving antiretroviral treatment as part of efforts to move Nigeria towards HIV epidemic control.     The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), administered by the U.S. Centers for Disease Control ...
Read More»
Show More ∨